| Tumor microbiome diversity and composition influence pancreatic cancer outcomes E Riquelme, Y Zhang, L Zhang, M Montiel, M Zoltan, W Dong, P Quesada, ... Cell 178 (4), 795-806. e12, 2019 | 1260 | 2019 |
| Analyzing microarray gene expression data GJ McLachlan, KA Do, C Ambroise John Wiley & Sons, 2005 | 960 | 2005 |
| Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia CS Tam, S O'Brien, W Wierda, H Kantarjian, S Wen, KA Do, DA Thomas, ... Blood, The Journal of the American Society of Hematology 112 (4), 975-980, 2008 | 928 | 2008 |
| Simplified staging for hepatocellular carcinoma JN Vauthey, GY Lauwers, NF Esnaola, KA Do, J Belghiti, N Mirza, ... Journal of clinical oncology 20 (6), 1527-1536, 2002 | 896 | 2002 |
| Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations JN Vauthey, A Chaoui, KA Do, MM Bilimoria, MJ Fenstermacher, ... Surgery 127 (5), 512-519, 2000 | 865 | 2000 |
| Steps toward mapping the human vasculature by phage display W Arap, MG Kolonin, M Trepel, J Lahdenranta, M Cardó-Vila, ... Nature medicine 8 (2), 121-127, 2002 | 772 | 2002 |
| Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer AM Gonzalez-Angulo, KM Timms, S Liu, H Chen, JK Litton, J Potter, ... Clinical Cancer Research 17 (5), 1082-1089, 2011 | 754 | 2011 |
| Body surface area and body weight predict total liver volume in Western adults JN Vauthey, EK Abdalla, DA Doherty, P Gertsch, MJ Fenstermacher, ... Liver transplantation 8 (3), 233-240, 2002 | 710 | 2002 |
| Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia W Wierda, S O’Brien, S Wen, S Faderl, G Garcia-Manero, D Thomas, ... Journal of clinical oncology 23 (18), 4070-4078, 2005 | 705 | 2005 |
| CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia S Ibrahim, M Keating, KA Do, S O'Brien, YO Huh, I Jilani, S Lerner, ... Blood, The Journal of the American Society of Hematology 98 (1), 181-186, 2001 | 661 | 2001 |
| Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells P Kebriaei, H Singh, MH Huls, MJ Figliola, R Bassett, S Olivares, B Jena, ... The Journal of clinical investigation 126 (9), 3363-3376, 2016 | 576 | 2016 |
| Morphology of sporadic colorectal cancer with DNA replication errors JR Jass, KA Do, LA Simms, H Iino, C Wynter, SP Pillay, J Searle, ... Gut 42 (5), 673-679, 1998 | 575 | 1998 |
| Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia WG Wierda, S O'Brien, X Wang, S Faderl, A Ferrajoli, KA Do, J Cortes, ... Blood, The Journal of the American Society of Hematology 109 (11), 4679-4685, 2007 | 465 | 2007 |
| Fingerprinting the circulating repertoire of antibodies from cancer patients PJ Mintz, J Kim, KA Do, X Wang, RG Zinner, M Cristofanilli, MA Arap, ... Nature biotechnology 21 (1), 57-63, 2003 | 443 | 2003 |
| Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation AM Tsimberidou, S O'Brien, I Khouri, FJ Giles, HM Kantarjian, R Champlin, ... Journal of Clinical Oncology 24 (15), 2343-2351, 2006 | 344 | 2006 |
| PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3 A Salameh, AK Lee, M Cardó-Vila, DN Nunes, E Efstathiou, FI Staquicini, ... Proceedings of the National Academy of Sciences 112 (27), 8403-8408, 2015 | 299 | 2015 |
| Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance T Manshouri, K Do, X Wang, FJ Giles, SM O'Brien, H Saffer, D Thomas, ... Blood, The Journal of the American Society of Hematology 101 (7), 2507-2513, 2003 | 251 | 2003 |
| Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma MM Bilimoria, GY Lauwers, DA Doherty, DM Nagorney, J Belghiti, KA Do, ... Archives of Surgery 136 (5), 528-535, 2001 | 249 | 2001 |
| PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors F Meric-Bernstam, A Akcakanat, H Chen, KA Do, T Sangai, F Adkins, ... Clinical cancer research 18 (6), 1777-1789, 2012 | 244 | 2012 |
| Longitudinal study of risk factors for coronary heart disease across the menopausal transition KA Do, A Green, JR Guthrie, EC Dudley, HG Burger, L Dennerstein American journal of epidemiology 151 (6), 584-593, 2000 | 244 | 2000 |